Literature DB >> 24000012

RACK1 promotes the proliferation of THP1 acute myeloid leukemia cells.

Dalin Zhang1, Qingyang Wang, Ting Zhu, Junxia Cao, Xueying Zhang, Jing Wang, Xiaoqian Wang, Yan Li, Beifen Shen, Jiyan Zhang.   

Abstract

The receptor for activated C kinase 1 (RACK1), an adaptor protein implicated in the regulation of multiple signaling pathways, has been reported to contribute to the survival of leukemic progenitor cells by enhancing the activity of glycogen synthase kinase 3β (GSK3β). However, it remains unknown whether RACK1 also contributes to the oncogenic growth of acute myeloid leukemia (AML) cells. Here, we report that transient or stable silencing of endogenous RACK1 expression by RACK1 short hairpin RNAs (shRNAs) led to impaired proliferation of THP1 AML cells without inducing terminal differentiation. Further exploration revealed that RACK1 loss-of-function resulted in reduced GSK3β activity. GSK3β shRNA treatment showed similar effects to RACK1 loss-of-function. Our data collectively suggest that RACK1 contributes to THP1 cell proliferation through, at least partially, enhancing GSK3β activity. Thus, targeting RACK1 may have some important therapeutic implications in the treatment of AML.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24000012     DOI: 10.1007/s11010-013-1798-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  15 in total

1.  Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways.

Authors:  Kyoko Arimoto; Hiroyuki Fukuda; Shinobu Imajoh-Ohmi; Haruo Saito; Mutsuhiro Takekawa
Journal:  Nat Cell Biol       Date:  2008-10-05       Impact factor: 28.824

2.  RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.

Authors:  Yue-Zhen Deng; Fan Yao; Jing-Jing Li; Zheng-Fa Mao; Ping-Ting Hu; Ling-Yun Long; Guo Li; Xiao-Dan Ji; Shuo Shi; Dong-Xian Guan; Yuan-Yuan Feng; Lei Cui; Dang-Sheng Li; Yong Liu; Xiang Du; Ming-Zhou Guo; Li-Yan Xu; En-Min Li; Hong-Yang Wang; Dong Xie
Journal:  Gastroenterology       Date:  2012-01-10       Impact factor: 22.682

Review 3.  Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development.

Authors:  Stefan E Hardt; Junichi Sadoshima
Journal:  Circ Res       Date:  2002-05-31       Impact factor: 17.367

4.  Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells.

Authors:  Jian Cui; Qingyang Wang; Jing Wang; Ming Lv; Ning Zhu; Yan Li; Jiannan Feng; Beifen Shen; Jiyan Zhang
Journal:  Mol Cancer Ther       Date:  2009-12       Impact factor: 6.261

5.  STAT3 exerts two-way regulation in the biological effects of IL-6 in M1 leukemia cells.

Authors:  J Zhang; B Shen; Y Li; Y Sun
Journal:  Leuk Res       Date:  2001-06       Impact factor: 3.156

6.  Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma.

Authors:  Yuanyuan Ruan; Linlin Sun; Yuqing Hao; Lijing Wang; Jiejie Xu; Wen Zhang; Jianhui Xie; Liang Guo; Lei Zhou; Xiaojing Yun; Hongguang Zhu; Aiguo Shen; Jianxin Gu
Journal:  J Clin Invest       Date:  2012-06-01       Impact factor: 14.808

7.  RACK1 mediates activation of JNK by protein kinase C [corrected].

Authors:  Pablo López-Bergami; Hasem Habelhah; Anindita Bhoumik; Weizhou Zhang; Lu-Hai Wang; Ze'ev Ronai
Journal:  Mol Cell       Date:  2005-08-05       Impact factor: 17.970

8.  A New alpha5beta1 integrin-dependent survival pathway through GSK3beta activation in leukemic cells.

Authors:  Fabienne De Toni-Costes; Mathieu Despeaux; Jessica Bertrand; Ezzeddine Bourogaa; Loïc Ysebaert; Bernard Payrastre; Claire Racaud-Sultan
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

9.  GSK3β inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb.

Authors:  Fangfang Zhou; Long Zhang; Theo van Laar; Hans van Dam; Peter Ten Dijke
Journal:  Mol Biol Cell       Date:  2011-07-27       Impact factor: 4.138

10.  Selective unresponsiveness to the inhibition of p38 MAPK activation by cAMP helps L929 fibroblastoma cells escape TNF-alpha-induced cell death.

Authors:  Jing Wang; Ruihong Tang; Ming Lv; Jiyan Zhang; Beifen Shen
Journal:  Mol Cancer       Date:  2010-01-13       Impact factor: 27.401

View more
  7 in total

1.  Dihydroartemisinin-induced apoptosis in human acute monocytic leukemia cells.

Authors:  Jia-Tian Cao; Hui-Min Mo; Yue Wang; Kai Zhao; Tian-Tian Zhang; Chang-Qian Wang; Kai-Lin Xu; Zhi-Hua Han
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

2.  Effect of fatty acids on melanogenesis and tumor cell growth in melanoma cells.

Authors:  Hidetoshi Yamada; Mayuka Hakozaki; Aiko Uemura; Tetsuro Yamashita
Journal:  J Lipid Res       Date:  2019-07-25       Impact factor: 5.922

3.  SEMA3C Supports Pancreatic Cancer Progression by Regulating the Autophagy Process and Tumor Immune Microenvironment.

Authors:  Dalin Zhang; Aaron Lindstrom; Edward J Kim; Chang-Il Hwang; Madison Lee Hall; Tzu-Yin Lin; Yuanpei Li
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

Review 4.  Genome Editing Targets for Improving Nutrient Use Efficiency and Nutrient Stress Adaptation.

Authors:  Lekshmy Sathee; B Jagadhesan; Pratheek H Pandesha; Dipankar Barman; Sandeep Adavi B; Shivani Nagar; G K Krishna; Shailesh Tripathi; Shailendra K Jha; Viswanathan Chinnusamy
Journal:  Front Genet       Date:  2022-06-14       Impact factor: 4.772

5.  The important role of the receptor for activated C kinase 1 (RACK1) in nasopharyngeal carcinoma progression.

Authors:  Hong Peng; Ping-Gui Gong; Jin-Bang Li; Long-Mei Cai; Le Yang; Yun-Yi Liu; Kai-Tai Yao; Xin Li
Journal:  J Transl Med       Date:  2016-05-11       Impact factor: 5.531

6.  Increased PKCα activity by Rack1 overexpression is responsible for chemotherapy resistance in T-cell acute lymphoblastic leukemia-derived cell line.

Authors:  Jie Lei; Qi Li; Ying Gao; Lei Zhao; Yanbo Liu
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

7.  GNA14's interaction with RACK1 inhibits hepatocellular carcinoma progression through reducing MAPK/JNK and PI3K/AKT signaling pathway.

Authors:  Cong Xu; Yi-Ming Li; Bo Sun; Fang-Jing Zhong; Lian-Yue Yang
Journal:  Carcinogenesis       Date:  2021-11-12       Impact factor: 4.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.